Analysis

Pharmacies report stockouts of pediatric oseltamivir suspension powder as influenza cases surge; some manufacturers still hold inventory, but supply pressure is rising.

US consumers are increasingly seeking clean‑ingredient women’s health products; Good Clean Love’s Almost Naked lubricant tops sales.

Effective control of drug stock, including expiry dates and storage conditions, impacts pharmacy revenue, cash flow, and tax burden.

After the 2025 OTC standard change, Hanmi and Dongkook launched ibuprofen‑combination cold medicines last winter, and this fall Chong Kun Dang and Dong‑A are entering, expanding market competition.

Dongkook Pharmaceutical’s dermal repair brand Madecaphamacia introduced the TECA Plus Formula Facial Repair Cream Light, featuring enhanced moisture, absorption, and added PDRN, available in ~6,000 Korean pharmacies.

The Korean Pharmaceutical Distribution Association and Paju city have signed an MOU to develop a 100,000‑pyeong pharmaceutical and biotech logistics complex within the Paju Peace Economic Zone.

Following MFDS removal of pediatric use for diacetyl hexyl smectite, demand shifted to HydraSec, causing shortages; Samjin Pharma expects supply normalization this week.

Taejeon Group has signed an exclusive distribution agreement with US health‑supplement brand Metagenics, aiming to launch its products to Korean pharmacists, healthcare professionals and consumers.

Following the shutdown of Erwinase’s manufacturer, Korea’s Rare & Essential Medicines Center signed a contract for Enrylaze, restoring treatment continuity for acute lymphoblastic leukemia and lymphoma patients.